P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971992.86050.85 |
_version_ | 1797280210250366976 |
---|---|
author | Dai-Hong Liu Chen Yao Donglin Yang Liping Dou Xiaoqiang Hou Kun Qian |
author_facet | Dai-Hong Liu Chen Yao Donglin Yang Liping Dou Xiaoqiang Hou Kun Qian |
author_sort | Dai-Hong Liu |
collection | DOAJ |
first_indexed | 2024-03-07T16:36:49Z |
format | Article |
id | doaj.art-dc914c4663044fa3b6680360402413bf |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:36:49Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-dc914c4663044fa3b6680360402413bf2024-03-03T09:43:12ZengWileyHemaSphere2572-92412023-08-017e860508510.1097/01.HS9.0000971992.86050.85202308003-01172P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIALDai-Hong Liu0Chen Yao1Donglin Yang2Liping Dou3Xiaoqiang Hou4Kun Qian51 The Fifth Medical Center of Chinese PLA General Hospital, China2 Peking University Clinical Research Institute, Peking University First Hospital3 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College1 The Fifth Medical Center of Chinese PLA General Hospital, China4 Platinumlife Biotechnology (Beijing) Co., Ltd.5 Nankai University, School of Medicine, Tianjin, Chinahttp://journals.lww.com/10.1097/01.HS9.0000971992.86050.85 |
spellingShingle | Dai-Hong Liu Chen Yao Donglin Yang Liping Dou Xiaoqiang Hou Kun Qian P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL HemaSphere |
title | P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL |
title_full | P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL |
title_fullStr | P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL |
title_full_unstemmed | P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL |
title_short | P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL |
title_sort | p1276 human umbilical cord derived mesenchymal stromal cell for the treatment of steroid refractory agvhd a multicenter randomized double blind phase 2 trial |
url | http://journals.lww.com/10.1097/01.HS9.0000971992.86050.85 |
work_keys_str_mv | AT daihongliu p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial AT chenyao p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial AT donglinyang p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial AT lipingdou p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial AT xiaoqianghou p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial AT kunqian p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial |